Clinical Trial

RAPid SimPLE Targeted Radiation Treatment for Brain Metastases

Study acronym: RAPPLE
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The aim of the study is to show that rapid, simple targeted radiotherapy to brain metastases with 8 Gy / 1 is non-inferior to 20 Gy / 5 in terms of overall survival for patients with poor prognosis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2021-09-17; most recent amendment 2025-04-15.
Status change: Not Yet Recruiting → Recruiting 2022-10-01
Trial Details
NCT Number NCT05050929
Lead Sponsor British Columbia Cancer Agency
Collaborators: Varian Medical Systems
Conditions Brain Metastases, Adult
Enrollment 100 participants
Start Date 2022-07-01
Primary Completion 2026-12-30 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2025-04-17